Medicine Grand Rounds: High Sensitivity Cardiac Troponin: Friend or Foe?

June 13, 2018 @ 8:00 am – 9:00 am
LKSC Berg Hall
Li Ka Shing Building
291 Campus Drive, Palo Alto, CA 94305
Talia Ochoa
Medicine Grand Rounds: High Sensitivity Cardiac Troponin: Friend or Foe? @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: David Morrow, MD
Director, Levine Cardiac Intensive Unit, Professor of Medicine                                                    Harvard Medical School

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS).

He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease.
Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management.

Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors.